Objective:To analyze the clinical characteristics and treatment regimens of 12 patients with coronavirus disease 2019（COVID-19）in Mianyang

Sichuan Province

China. Methods:We enrolled 12 consecutive confirmed patients with COVID-19 hospitalized in Mianyang from January 24 to February 10

2020

and collected their data about general information

epidemiological history

clinical manifestations

laboratory test results

chest imaging findings

and treatment regimens. According to"Diagnosis and Treatment Protocol for Coronavirus Disease2019（Trial version 6）"

the patients were classified as mild

moderate

severe

or critical. Results:The mean age of the patients was 39.25 ± 19.20 years. Five（41.7%）patients had comorbidities. There were no mild case

seven（58.3%）moderate cases

three（25%）severe cases

and two（16.7%）critical cases. The main symptoms were fever（91.6%）

cough（66.7%）

headache（33.3%）

chest pain（25.0%）

and dizziness（25.0%）. Laboratory tests showed that ten patients had an increased erythrocyte sedimentation rate; the two critical cases exhibited an oxygenation index of less than 200

increased lactic acid levels

and decreased leukocyte and lymphocyte counts. All the patients were given two or more antiviral drugs; five received glucocorticoid therapy; five were treated with traditional Chinese medicine; two were supported by mechanical ventilation in the prone position. Conclusion:Some patients with COVID-19 in Mianyang are young

41.7% of the total patients have underlying diseases

and some cases manifest with chest pain. Severe or critical patients benefit from glucocorticoid therapy and mechanical ventilation in the prone position.